Table 2.
Number of patients who were exposed to statins and other lipid lowering agents
| Medication | Number (%) of patients who had exposure to medication | Cumulative duration (years) of exposure to medication |
|---|---|---|
| Any statin | 96,182 (25.3) | 165,083 |
| Atorvastatin | 61,157 (16.1) | 78,627 |
| Rosuvastatin | 11,720 (3.1) | 14,678 |
| Pitavastatin | 8010 (2.1) | 7691 |
| Pravastatin | 8047 (2.1) | 8099 |
| Simvastatin | 46,773 (12.3) | 46,768 |
| Lovastatin | 9291 (2.4) | 6045 |
| Fluvastatin | 3786 (1.0) | 3175 |
| Fibratea | 14,926 (3.9) | 11,617 |
| Ezetimibe | 5847 (1.5) | 5830 |
Data are based on time period between baseline and last health examination of each subject
aBezafibrate, ciprofibrate, etofibrate, fenofibrate, and gemfibrozil